Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort.
MS
disability
immunotherapy
prediction score
Journal
CNS neuroscience & therapeutics
ISSN: 1755-5949
Titre abrégé: CNS Neurosci Ther
Pays: England
ID NLM: 101473265
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
05
01
2022
received:
30
11
2021
accepted:
05
01
2022
pubmed:
22
1
2022
medline:
8
4
2022
entrez:
21
1
2022
Statut:
ppublish
Résumé
Survival analysis of reaching EDSS ≥4.0 based on RoAD score ≥4 (dashed line) and <4 (solid line) by Cox regression analysis. (A) Unadjusted regression analysis. (B) Regression controlled for sex and immunotherapy groups, and the trajectory of treatment changes during follow-up.
Identifiants
pubmed: 35060326
doi: 10.1111/cns.13806
pmc: PMC8981428
doi:
Substances chimiques
Immunologic Factors
0
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
792-795Informations de copyright
© 2022 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.
Références
Curr Opin Neurol. 2018 Jun;31(3):233-243
pubmed: 29634596
Nat Rev Neurol. 2019 May;15(5):287-300
pubmed: 30940920
Acta Neurol Belg. 2021 Dec;121(6):1699-1706
pubmed: 32997326
Brain. 2015 Jul;138(Pt 7):1863-74
pubmed: 25902415
JAMA Neurol. 2019 Jul 1;76(7):841-849
pubmed: 31034002
J Neurol. 2022 Jan;269(1):452-459
pubmed: 34596743
Ann Neurol. 2017 Jun;81(6):857-870
pubmed: 28512753
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Eur J Neurol. 2021 Dec;28(12):4153-4166
pubmed: 34487400
Eur J Neurol. 2021 Aug;28(8):2533-2542
pubmed: 33786942
Ann Neurol. 2021 Sep;90(3):477-489
pubmed: 34057235